These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37324446)

  • 1. A perfused multi-well bioreactor platform to assess tumor organoid response to a chemotherapeutic gradient.
    Wasson EM; He W; Ahlquist J; Hynes WF; Triplett MG; Hinckley A; Karelehto E; Gray-Sherr DR; Friedman CF; Robertson C; Shusteff M; Warren R; Coleman MA; Moya ML; Wheeler EK
    Front Bioeng Biotechnol; 2023; 11():1193430. PubMed ID: 37324446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
    Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
    Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogel-based colorectal cancer organoid co-culture models.
    Luo X; Fong ELS; Zhu C; Lin QXX; Xiong M; Li A; Li T; Benoukraf T; Yu H; Liu S
    Acta Biomater; 2021 Sep; 132():461-472. PubMed ID: 33388439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFlowPlate-A Customized 384-Well Plate for the Culture of Perfusable Vascularized Colon Organoids.
    Rajasekar S; Lin DSY; Abdul L; Liu A; Sotra A; Zhang F; Zhang B
    Adv Mater; 2020 Nov; 32(46):e2002974. PubMed ID: 33000879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Derived Organoid Model in the Prediction of Chemotherapeutic Drug Response in Colorectal Cancer.
    Hao M; Cao Z; Wang Z; Xin J; Kong B; Xu J; Zhang L; Chen P
    ACS Biomater Sci Eng; 2022 Aug; 8(8):3515-3525. PubMed ID: 35696669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematically Reduced Mathematical Model for Organoid Expansion.
    Ellis MA; Dalwadi MP; Ellis MJ; Byrne HM; Waters SL
    Front Bioeng Biotechnol; 2021; 9():670186. PubMed ID: 34178962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy.
    Ubink I; Bolhaqueiro ACF; Elias SG; Raats DAE; Constantinides A; Peters NA; Wassenaar ECE; de Hingh IHJT; Rovers KP; van Grevenstein WMU; Laclé MM; Kops GJPL; Borel Rinkes IHM; Kranenburg O
    Br J Surg; 2019 Sep; 106(10):1404-1414. PubMed ID: 31197820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal organoids on-a-chip: a micro-millifluidic bioreactor for long-term organoid maintenance.
    Xue Y; Seiler MJ; Tang WC; Wang JY; Delgado J; McLelland BT; Nistor G; Keirstead HS; Browne AW
    Lab Chip; 2021 Sep; 21(17):3361-3377. PubMed ID: 34236056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-organ-chip co-culture of liver and testis equivalents: a first step toward a systemic male reprotoxicity model.
    Baert Y; Ruetschle I; Cools W; Oehme A; Lorenz A; Marx U; Goossens E; Maschmeyer I
    Hum Reprod; 2020 May; 35(5):1029-1044. PubMed ID: 32390056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
    Zhou Z; Cong L; Cong X
    Front Oncol; 2021; 11():762184. PubMed ID: 35036354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Organoid-Based Preclinical Model of Human Gastric Cancer.
    Steele NG; Chakrabarti J; Wang J; Biesiada J; Holokai L; Chang J; Nowacki LM; Hawkins J; Mahe M; Sundaram N; Shroyer N; Medvedovic M; Helmrath M; Ahmad S; Zavros Y
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):161-184. PubMed ID: 30522949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug screening by uniform patient derived colorectal cancer hydro-organoids.
    Jung YH; Choi DH; Park K; Lee SB; Kim J; Kim H; Jeong HW; Yang JH; Kim JA; Chung S; Min BS
    Biomaterials; 2021 Sep; 276():121004. PubMed ID: 34273688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microengineered Multi-Organoid System from hiPSCs to Recapitulate Human Liver-Islet Axis in Normal and Type 2 Diabetes.
    Tao T; Deng P; Wang Y; Zhang X; Guo Y; Chen W; Qin J
    Adv Sci (Weinh); 2022 Feb; 9(5):e2103495. PubMed ID: 34951149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system.
    Wang Y; Wang H; Deng P; Chen W; Guo Y; Tao T; Qin J
    Lab Chip; 2018 Dec; 18(23):3606-3616. PubMed ID: 30357207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer.
    He X; Jiang Y; Zhang L; Li Y; Hu X; Hua G; Cai S; Mo S; Peng J
    Front Bioeng Biotechnol; 2023; 11():1190637. PubMed ID: 37284236
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a bioreactor with stacked sheet shaped organoids of primary hepatocytes.
    Kusumi T; Ishihara K; Mizumoto H; Nakazawa K; Ijima H; Funatsu K; Kajiwara T
    J Biosci Bioeng; 2009 May; 107(5):552-5. PubMed ID: 19393557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
    Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
    Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform.
    Forsythe SD; Sasikumar S; Moaven O; Sivakumar H; Shen P; Levine EA; Soker S; Skardal A; Votanopoulos KI
    Ann Surg Oncol; 2020 Dec; 27(13):4950-4960. PubMed ID: 32632882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded Study.
    Wang T; Pan W; Zheng H; Zheng H; Wang Z; Li JJ; Deng C; Yan J
    Dis Colon Rectum; 2021 Jul; 64(7):833-850. PubMed ID: 33709991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.